Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans
- PMID: 363492
- DOI: 10.2337/diab.27.12.1205
Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans
Abstract
The rate of alloxan-induced insulin release was measured from rat islets maintained in a simple perifusion system. Insulin release during the five-minute exposure to alloxan reached its maximum rate after two to three minutes of the exposure and then rapidly declined. This insulin release was dependent upon extracellular calcium and was associated with an increased 45Ca uptake by isolated islets. Once exposed to alloxan, however, the islets did not release insulin when stimulated again with D-glucose or alloxan. These effects of alloxan on insulin release (stimulation and subsequent inhibition) and the increased 45Ca uptake were prevented by the presence of 3-0-methyl-D-glucose during the alloxan exposure. These findings indicate a close correlation between alloxan-induced insulin release and the subsequent inhibition of further insulin release. D-glucose, when present during the entire five-minute exposure to alloxan, protected competitively against alloxan inhibition of insulin release. In addition, D-glucose, when present immediately after brief (one to three minutes) alloxan exposures, reversed some of the subsequent inhibition of insulin release. These findings suggest that alloxan and D-glucose were competing for a common site on the beta-cell. The possibility of this site being a receptor responsible for the initiation of insulin release is discussed.
Similar articles
-
Alloxan uptake by isolated rat islets of Langerhans.Endocrinology. 1978 Jun;102(6):1847-55. doi: 10.1210/endo-102-6-1847. Endocrinology. 1978. PMID: 369835
-
Mechanism of barbituric-acid protection against inhibition by alloxan of glucose-induced insulin release.Diabetes. 1978 Feb;27(2):71-7. doi: 10.2337/diab.27.2.71. Diabetes. 1978. PMID: 342321
-
Glucose and 3-O-methylglucose protection against alloxan poisoning of pancreatic alpha and beta cells.Diabetes. 1977 Oct;26(10):973-9. doi: 10.2337/diab.26.10.973. Diabetes. 1977. PMID: 332568
-
Effects of alloxan on glucose-stimulated insulin secretion, glucose metabolism, and cyclic adenosine 3', 5'-monophosphate levels in rat isolated islets of langerhans.Diabetologia. 1979 Feb;16(2):115-20. doi: 10.1007/BF01225460. Diabetologia. 1979. PMID: 215480
-
Alloxan toxicity to the pancreatic B-cell. A new hypothesis.Biochem Pharmacol. 1982 Nov 15;31(22):3527-34. doi: 10.1016/0006-2952(82)90571-8. Biochem Pharmacol. 1982. PMID: 6758791 Review. No abstract available.
Cited by
-
Rodent models for diabetes.3 Biotech. 2023 Mar;13(3):80. doi: 10.1007/s13205-023-03488-0. Epub 2023 Feb 9. 3 Biotech. 2023. PMID: 36778766 Free PMC article. Review.
-
Effects of dehydrouramil on protein phosphorylation and insulin secretion in rat islets of Langerhans.Biochem J. 1986 Jul 1;237(1):191-6. doi: 10.1042/bj2370191. Biochem J. 1986. PMID: 3026310 Free PMC article.
-
Rodent animal models: from mild to advanced stages of diabetic nephropathy.Inflammopharmacology. 2014 Oct;22(5):279-93. doi: 10.1007/s10787-014-0215-y. Epub 2014 Aug 23. Inflammopharmacology. 2014. PMID: 25149089 Free PMC article. Review.
-
A system-level approach to investigate alloxan-induced toxicity in microtubule-binding protein to lead type 2 diabetes mellitus.Mol Divers. 2021 May;25(2):911-924. doi: 10.1007/s11030-020-10075-5. Epub 2020 Mar 26. Mol Divers. 2021. PMID: 32219736
-
Alloxan: history and mechanism of action.Diabetologia. 1988 Jun;31(6):337-42. doi: 10.1007/BF02341500. Diabetologia. 1988. PMID: 3046975 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources